Cargando…
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium
The objective of this study was to investigate the incidence and risk factors associated with COVID-19 vaccine breakthrough infections. We included all persons ≥18 years that had been fully vaccinated against COVID-19 for ≥14 days, between 1 February 2021 and 5 December 2021, in Belgium. The inciden...
Autores principales: | Stouten, Veerle, Hubin, Pierre, Haarhuis, Freek, van Loenhout, Joris A. F., Billuart, Matthieu, Brondeel, Ruben, Braeye, Toon, Van Oyen, Herman, Wyndham-Thomas, Chloé, Catteau, Lucy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029338/ https://www.ncbi.nlm.nih.gov/pubmed/35458532 http://dx.doi.org/10.3390/v14040802 |
Ejemplares similares
-
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
por: Braeye, Toon, et al.
Publicado: (2023) -
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021
por: Braeye, Toon, et al.
Publicado: (2022) -
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
por: Braeye, Toon, et al.
Publicado: (2023) -
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
por: Vermeiren, Elias, et al.
Publicado: (2023) -
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
por: Van Goethem, Nina, et al.
Publicado: (2022)